1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Couple looking at their phone surprised, symbolising a bargain buy.
    Healthcare Shares

    How big could the return be with CSL shares in 2024?

    | James Mickleboro

    Could this biotech company be a market beater in 2024?

    Read more »

    A young man goes over his finances and investment portfolio at home.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    A woman jumps for joy with a rocket drawn on the wall behind her.
    Broker Notes

    Morgans names the best ASX 200 shares to buy in December

    | James Mickleboro

    Morgans is expecting strong returns from these top ASX 200 shares over the next 12 months.

    Read more »

    Five arrows hit the bullseye of five round targets lined up in a row, with a blue sky in the background.
    Healthcare Shares

    When might CSL shares hit the $300-mark again?

    | Sebastian Bowen

    CSL is on track for $300, if one broker is to be believed.

    Read more »

    A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    A couple are shocked and elated at the good news they've just seen on their devices.
    Growth Shares

    Analysts say these ASX 200 growth shares could rise 20%+

    | James Mickleboro

    Big returns could be on the cards from these shares.

    Read more »

    Person with a handful of Australian dollar notes, symbolising dividends.
    Dividend Investing

    Which ASX 200 healthcare share will pay the best dividend yield in FY24?

    | Bronwyn Allen

    Healthcare stocks are a traditional defensive play in challenging economic times.

    Read more »

    Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
    Broker Notes

    CSL shares up 15% in 5 weeks amid two hedge funds placing opposing bets

    | Bronwyn Allen

    Let's see what these funds have to say about CSL shares.

    Read more »

    A stoke broker watches the share price movements on the Asian share market
    Broker Notes

    Goldman Sachs says these ASX 200 shares are the best buys in the Asia-Pacific region

    | James Mickleboro

    These stocks could be the best of the best in the region

    Read more »

    A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
    Healthcare Shares

    The CSL share price return tripled the ASX 200 in November

    | Tristan Harrison

    November saw a very healthy return for CSL shares.

    Read more »

    three children wearing superhero costumes, complete with masks, pose with hands on hips wearing capes and sneakers on a running track.
    Investing Strategies

    The 3 best deals on the ASX today

    | Tony Yoo

    Grab these stocks while they're cheap before interest rates stop rising.

    Read more »

    A young man goes over his finances and investment portfolio at home.
    How to invest

    How to exploit the ASX's current weakness for long-term gain

    | James Mickleboro

    Market weakness doesn't need to be the enemy. It can be your best friend.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note